Three Allergens Subcutaneous Inmunotherapy In Polen-Allergic Patients: Our Experience

Isabel Torres Rojas,Paula Lopez-Gonzalez,Diana Perez-Alzate,Elisa Haroun-Diaz,Natalia Blanca-Lopez,Maria Luisa Somoza Alvarez,Ana Prieto-Moreno Pfeifer,Maria Desamparados Cervera,Carlos Blanco Mota,Maria Vazquez de la Torre,Francisco Javier Ruano

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2022）

Cited 0|Views20
No score
Abstract
Allergen immunotherapy is the only disease-modifying treatment for allergic asthma and allergic rhinoconjunctivitis (RC). The objective of this study was to describe our experience in patients under treatment with three allergens subcutaneous immunotherapy (SCIT).
More
Translated text
Key words
allergens subcutaneous inmunotherapy,polen-allergic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined